Literature DB >> 7649569

Isolated diastolic hypertension. A favorable finding among young and middle-aged hypertensive subjects.

J Fang1, S Madhavan, H Cohen, M H Alderman.   

Abstract

To identify pretreatment characteristics associated with subsequent myocardial infarction in young and middle-aged previously untreated hypertensive individuals, we examined the experience of 1560 participants in a work-site hypertension control program who were younger than 60 years. Subjects were categorized by initial blood pressure as having isolated diastolic hypertension (< 160/> or = 90 mm Hg, n = 965) or combined systolic and diastolic hypertension (> or = 160/> or = 90 mm Hg, n = 595). During 4.5 years of follow-up, there were 24 myocardial infarctions, yielding an overall incidence of 3.89 per 1000 person-years. Subjects with systolic/diastolic hypertension were older, had higher cholesterol and blood sugar levels, and included more smokers and people with left ventricular hypertrophy on electrocardiogram than those with isolated diastolic hypertension. Age-adjusted incidence rates for myocardial infarction were 5.20 and 2.21 per 1000 person-years in systolic/diastolic hypertension and isolated diastolic hypertension, respectively, and the relative risk of systolic/diastolic hypertension was 2.31 (95% confidence interval, 1.29-4.15). Among subjects with isolated diastolic hypertension, no myocardial infarction occurred in those with systolic pressure less than 140 mm Hg. Cox regression analysis including other known risk factors showed that pulse pressure, as a continuous variable (hazards ratio, 1.54; 95% confidence interval, 1.08-2.20), and type of hypertension, ie, systolic/diastolic hypertension versus isolated diastolic hypertension (hazards ratio, 2.11; 95% confidence interval, 1.08-4.13), were independently associated with myocardial infarction. These results suggest that young and middle-aged treated hypertensive individuals with normal pretreatment systolic pressure enjoy a more favorable prognosis than do those with systolic elevation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7649569     DOI: 10.1161/01.hyp.26.3.377

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  22 in total

1.  Isolated Diastolic Hypertension in the UK Biobank: Comparison of ACC/AHA and ESC/NICE Guideline Definitions.

Authors:  John W McEvoy; Nilanjan Chatterjee; Brian P McGrath; Prosenjit Kundu; Natalie Daya; Josef Coresh; Elizabeth Selvin
Journal:  Hypertension       Date:  2020-07-27       Impact factor: 10.190

Review 2.  Cardiovascular risks associated with diastolic blood pressure and isolated diastolic hypertension.

Authors:  Yan Li; Fang-Fei Wei; Shuai Wang; Yi-Bang Cheng; Ji-Guang Wang
Journal:  Curr Hypertens Rep       Date:  2014-11       Impact factor: 5.369

3.  Target blood pressure for antihypertensive therapy in patients with proteinuric renal disease.

Authors:  L A Hebert
Journal:  Curr Hypertens Rep       Date:  1999-10       Impact factor: 5.369

Review 4.  [Isolated systolic hypertension. An independent disease].

Authors:  J Scholze
Journal:  Herz       Date:  2010-10-16       Impact factor: 1.443

5.  Prevalence of isolated diastolic hypertension and associated risk factors among adults in Kanpur, India.

Authors:  Tanu Midha; Arati Lalchandani; Bhola Nath; Ranjeeta Kumari; Umeshwar Pandey
Journal:  Indian Heart J       Date:  2012-06-21

6.  Blood pressure tracking over the adult life course: patterns and correlates in the Framingham heart study.

Authors:  Susan Cheng; Vanessa Xanthakis; Lisa M Sullivan; Ramachandran S Vasan
Journal:  Hypertension       Date:  2012-10-29       Impact factor: 10.190

7.  Association of Isolated Diastolic Hypertension as Defined by the 2017 ACC/AHA Blood Pressure Guideline With Incident Cardiovascular Outcomes.

Authors:  John W McEvoy; Natalie Daya; Faisal Rahman; Ron C Hoogeveen; Roger S Blumenthal; Amil M Shah; Christie M Ballantyne; Josef Coresh; Elizabeth Selvin
Journal:  JAMA       Date:  2020-01-28       Impact factor: 56.272

8.  Hypothesis: it is time to reconsider phenotypes in hypertension.

Authors:  Marcelo Orias; Aldo H Tabares; Aldo J Peixoto
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-05       Impact factor: 3.738

9.  Abnormal cardiac and metabolic measures correlate significantly with lower performance and activity in overweight chronic liver disease.

Authors:  Jillian Price; Carey Escheik; Ali Weinstein; Patrice Winter; Lynn Gerber; Zobair Younossi
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-17       Impact factor: 3.738

Review 10.  Isolated diastolic hypertension.

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Nov-Dec       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.